Welcome to LookChem.com Sign In|Join Free

CAS

  • or

120014-30-4

Post Buying Request

120014-30-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

120014-30-4 Usage

Chemical Properties

Pale Yellow Solid

Uses

5,6-Dimethoxy-2-[(4-piperidyl)methyl]indan-1-one is an impurity of Donepezil (D531750), an inhibitor of acetylcholinesterase.

Check Digit Verification of cas no

The CAS Registry Mumber 120014-30-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,0,1 and 4 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 120014-30:
(8*1)+(7*2)+(6*0)+(5*0)+(4*1)+(3*4)+(2*3)+(1*0)=44
44 % 10 = 4
So 120014-30-4 is a valid CAS Registry Number.
InChI:InChI=1/C17H23NO3/c1-20-15-9-12-8-13(7-11-3-5-18-6-4-11)17(19)14(12)10-16(15)21-2/h9-11,13,18H,3-8H2,1-2H3

120014-30-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydroinden-1-one

1.2 Other means of identification

Product number -
Other names 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:120014-30-4 SDS

120014-30-4Synthetic route

2-(pyridin-4-yl)methyl-5,6-dimethoxy-1-indanone
4803-57-0

2-(pyridin-4-yl)methyl-5,6-dimethoxy-1-indanone

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
With hydrogen; platinum(IV) oxide In methanol; acetic acid at 20℃; under 2311.54 Torr; for 6h;99%
With palladium on activated charcoal; hydrogen; acetic acid In methanol74%
With 5% Pd(II)/C(eggshell); hydrogen; sodium acetate; acetic acid In methanol; dichloromethane at 70 - 75℃; under 4413.43 - 5149.01 Torr; for 10h;70%
donepezil
120014-06-4

donepezil

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
With ammonium formate; palladium 10% on activated carbon In methanol at 20℃; for 3h; Heating / reflux;97%
With hydrogen In methanol at 20℃; under 760.051 Torr; for 72h;
5,6-dimethoxy-2-(4-piperidinylmethyl)-indan-1-one acetate
861675-47-0

5,6-dimethoxy-2-(4-piperidinylmethyl)-indan-1-one acetate

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
In water pH=13;95.3%
(E)-tert-butyl 4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)piperidine-1-carboxylate

(E)-tert-butyl 4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)piperidine-1-carboxylate

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Stage #1: (E)-tert-butyl 4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)piperidine-1-carboxylate With palladium 10% on activated carbon; hydrogen In tetrahydrofuran at 20℃; under 760.051 Torr; for 0.333333h;
Stage #2: With hydrogenchloride In water; ethyl acetate at 20℃; for 3h;
91%
(E)-5, 6-dimethoxy-2-(pyridin-4-ylmethylene)-2, 3-dihydro-1H-inden-1-one
877606-65-0

(E)-5, 6-dimethoxy-2-(pyridin-4-ylmethylene)-2, 3-dihydro-1H-inden-1-one

A

2-(pyridin-4-yl)methyl-5,6-dimethoxy-1-indanone
4803-57-0

2-(pyridin-4-yl)methyl-5,6-dimethoxy-1-indanone

B

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
With hydrogen; acetic acid; palladium on activated charcoal In methanol at 60 - 65℃; for 7h;A n/a
B 90%
5,6-dimethoxy-3-(pyridine-4-yl)spiro[indene-2,2'-oxiran]-1(3H)-one

5,6-dimethoxy-3-(pyridine-4-yl)spiro[indene-2,2'-oxiran]-1(3H)-one

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
With perchloric acid; 5% Pd(II)/C(eggshell); hydrogen In methanol; dichloromethane at 60 - 65℃; under 4781.22 Torr; for 10h;90%
tert-butyl 4-((2,3-dihydro-5,6-dimethoxy-1-oxo-1H-inden-2-yl)-methyl)piperidine-1-carboxylate
948550-60-5

tert-butyl 4-((2,3-dihydro-5,6-dimethoxy-1-oxo-1H-inden-2-yl)-methyl)piperidine-1-carboxylate

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Stage #1: tert-butyl 4-((2,3-dihydro-5,6-dimethoxy-1-oxo-1H-inden-2-yl)-methyl)piperidine-1-carboxylate With hydrogenchloride In ethyl acetate
Stage #2: With sodium carbonate In water; ethyl acetate pH=~ 6;
84%
With trifluoroacetic acid In dichloromethane at 0 - 20℃; for 4h;80%
(2E)-5,6-dimethoxy-2-(pyridin-4-yl-methylene)indan-1-one-N-oxide

(2E)-5,6-dimethoxy-2-(pyridin-4-yl-methylene)indan-1-one-N-oxide

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
With palladium on activated charcoal; hydrogen In methanol; dichloromethane at 75 - 80℃; under 7355.72 Torr; for 8h;77%
5,6-dimethoxy-3-(pyridine-4-yl)spiro[indene-2,2'-oxiran]-1(3H)-one

5,6-dimethoxy-3-(pyridine-4-yl)spiro[indene-2,2'-oxiran]-1(3H)-one

A

4-((5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl)piperidine
844694-83-3

4-((5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl)piperidine

B

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
With perchloric acid; palladium 10% on activated carbon; hydrogen In methanol at 70 - 75℃; under 4413.43 - 5149.01 Torr; for 7h;A 22%
B 63%
4-piperidinemethanol
6457-49-4

4-piperidinemethanol

5,6-dimethoxy-1-indanone
2107-69-9

5,6-dimethoxy-1-indanone

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
With trifuran-2-yl-phosphane; C42H32F3N2O2PPd; lithium hydroxide In neat (no solvent) at 100℃; for 48h; Schlenk technique; Sealed tube; Inert atmosphere; Green chemistry; chemoselective reaction;51%
pyridine-4-carbaldehyde
872-85-5

pyridine-4-carbaldehyde

N6-protected N2-Fmoc-lysine on Wang resin

N6-protected N2-Fmoc-lysine on Wang resin

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 95.6 percent / p-toluenesulfonic acid / toluene / 6 h / Heating
2: 90 percent / hydrogen; acetic acid / palladium on activated charcoal / methanol / 7 h / 60 - 65 °C
View Scheme
5,6-dimethoxy-1-indanone
2107-69-9

5,6-dimethoxy-1-indanone

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 95.6 percent / p-toluenesulfonic acid / toluene / 6 h / Heating
2: 90 percent / hydrogen; acetic acid / palladium on activated charcoal / methanol / 7 h / 60 - 65 °C
View Scheme
Multi-step reaction with 3 steps
1: toluene-4-sulfonic acid / toluene / Reflux
2: dihydrogen peroxide / acetic acid / 45 - 50 °C
3: palladium on activated charcoal; hydrogen / methanol; dichloromethane / 8 h / 75 - 80 °C / 7355.72 Torr
View Scheme
Multi-step reaction with 2 steps
1.1: sodium hydride / tetrahydrofuran; mineral oil / 0.5 h
1.2: 2 h / 20 °C
2.1: palladium 10% on activated carbon; hydrogen / tetrahydrofuran / 0.33 h / 20 °C / 760.05 Torr
2.2: 3 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: toluene-4-sulfonic acid / toluene / 24 h / Reflux
2: hydrogen / neat (no solvent) / 144 h / 50 °C / 760.05 Torr
View Scheme
Multi-step reaction with 2 steps
1: toluene-4-sulfonic acid / toluene
2: acetic acid; palladium on activated charcoal; hydrogen / methanol
View Scheme
1-benzyl-4-<(5,6-dimethoxy-1-oxoindan-2-ylidenyl)methyl>piperidine
120014-07-5

1-benzyl-4-<(5,6-dimethoxy-1-oxoindan-2-ylidenyl)methyl>piperidine

A

donepezil hydrochloride

donepezil hydrochloride

B

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Stage #1: 1-benzyl-4-<(5,6-dimethoxy-1-oxoindan-2-ylidenyl)methyl>piperidine With hydrogen; 5% Pd on alumina In tetrahydrofuran at 3 - 6℃; under 3000.3 - 7500.75 Torr; for 3 - 5h;
Stage #2: With hydrogenchloride In tetrahydrofuran; ethanol; water Product distribution / selectivity;
Stage #1: 1-benzyl-4-<(5,6-dimethoxy-1-oxoindan-2-ylidenyl)methyl>piperidine With hydrogen; 5% Pd on alumina In tetrahydrofuran at 14 - 20℃; under 3750.38 - 7500.75 Torr; for 0.833333h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water
Stage #1: 1-benzyl-4-<(5,6-dimethoxy-1-oxoindan-2-ylidenyl)methyl>piperidine With hydrogen; 5% Pd on alumina In toluene at 9 - 12℃; under 1500.15 - 6000.6 Torr; for 2.33333 - 5h;
Stage #2: With hydrogenchloride In ethanol; water; toluene Product distribution / selectivity;
Stage #1: 1-benzyl-4-<(5,6-dimethoxy-1-oxoindan-2-ylidenyl)methyl>piperidine With hydrogen; 5%-palladium/activated carbon In tetrahydrofuran; toluene at 30 - 60℃; under 1551.49 - 1810.07 Torr; for 2h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water; toluene at 25 - 30℃; Product distribution / selectivity;
1-benzyl-4-<(5,6-dimethoxy-1-oxoindan-2-ylidenyl)methyl>piperidine
120014-07-5

1-benzyl-4-<(5,6-dimethoxy-1-oxoindan-2-ylidenyl)methyl>piperidine

A

donepezil
120014-06-4

donepezil

B

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
With hydrogen; palladium 10% on activated carbon In tetrahydrofuran at 0 - 2℃; under 760.051 Torr; for 1.5h;
With hydrogen; palladium 10% on activated carbon In toluene at 0 - 1℃; under 6000.6 - 7500.75 Torr; for 5h;
5,6-dimethoxy-2-[1-(4-pyridinyl)methylidene]-1-indanone tosylate

5,6-dimethoxy-2-[1-(4-pyridinyl)methylidene]-1-indanone tosylate

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
With hydrogen; palladium 10% on activated carbon In water at 60 - 95℃; under 7500.75 Torr; for 8h;
5,6-dimethoxy-2-(pyridine-4-ylmethylene)indan-1-one hydrochloride
942424-77-3

5,6-dimethoxy-2-(pyridine-4-ylmethylene)indan-1-one hydrochloride

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
With hydrogen; acetic acid; palladium 10% on activated carbon In methanol at 68 - 72℃; under 3800.26 Torr; for 7h;
pyridine-4-carbaldehyde
872-85-5

pyridine-4-carbaldehyde

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: toluene-4-sulfonic acid / toluene / Reflux
2: dihydrogen peroxide / acetic acid / 45 - 50 °C
3: palladium on activated charcoal; hydrogen / methanol; dichloromethane / 8 h / 75 - 80 °C / 7355.72 Torr
View Scheme
Multi-step reaction with 2 steps
1: toluene-4-sulfonic acid / toluene / 24 h / Reflux
2: hydrogen / neat (no solvent) / 144 h / 50 °C / 760.05 Torr
View Scheme
Multi-step reaction with 2 steps
1: toluene-4-sulfonic acid / toluene
2: acetic acid; palladium on activated charcoal; hydrogen / methanol
View Scheme
(E)-5, 6-dimethoxy-2-(pyridin-4-ylmethylene)-2, 3-dihydro-1H-inden-1-one
877606-65-0

(E)-5, 6-dimethoxy-2-(pyridin-4-ylmethylene)-2, 3-dihydro-1H-inden-1-one

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dihydrogen peroxide / acetic acid / 45 - 50 °C
2: palladium on activated charcoal; hydrogen / methanol; dichloromethane / 8 h / 75 - 80 °C / 7355.72 Torr
View Scheme
With hydrogen In neat (no solvent) at 50℃; under 760.051 Torr; for 144h;
4-piperidinemethanol
6457-49-4

4-piperidinemethanol

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: tetrahydrofuran; ethyl acetate / 6 h / 20 °C
2.1: 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione / ethyl acetate / 4 h / Inert atmosphere; Reflux
3.1: tetrabutylammomium bromide; sodium hydroxide / dichloromethane; water / 0.5 h / 20 °C / Inert atmosphere
3.2: 5 h / 50 °C / Inert atmosphere
4.1: diphenylsilane; zinc(II) chloride; tetrakis(triphenylphosphine) palladium(0) / chloroform / 24 h / 20 °C
5.1: trifluoroacetic acid / dichloromethane / 4 h / 0 - 20 °C
View Scheme
tert butyl 4-formylpiperidine-1-carboxylate
137076-22-3

tert butyl 4-formylpiperidine-1-carboxylate

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: tetrabutylammomium bromide; sodium hydroxide / dichloromethane; water / 0.5 h / 20 °C / Inert atmosphere
1.2: 5 h / 50 °C / Inert atmosphere
2.1: diphenylsilane; zinc(II) chloride; tetrakis(triphenylphosphine) palladium(0) / chloroform / 24 h / 20 °C
3.1: trifluoroacetic acid / dichloromethane / 4 h / 0 - 20 °C
View Scheme
Multi-step reaction with 2 steps
1.1: sodium hydride / tetrahydrofuran; mineral oil / 0.5 h
1.2: 2 h / 20 °C
2.1: palladium 10% on activated carbon; hydrogen / tetrahydrofuran / 0.33 h / 20 °C / 760.05 Torr
2.2: 3 h / 20 °C
View Scheme
4-carbethoxypiperidine
1126-09-6

4-carbethoxypiperidine

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: lithium aluminium tetrahydride / tetrahydrofuran / 0 - 20 °C
2.1: tetrahydrofuran; ethyl acetate / 6 h / 20 °C
3.1: 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione / ethyl acetate / 4 h / Inert atmosphere; Reflux
4.1: tetrabutylammomium bromide; sodium hydroxide / dichloromethane; water / 0.5 h / 20 °C / Inert atmosphere
4.2: 5 h / 50 °C / Inert atmosphere
5.1: diphenylsilane; zinc(II) chloride; tetrakis(triphenylphosphine) palladium(0) / chloroform / 24 h / 20 °C
6.1: trifluoroacetic acid / dichloromethane / 4 h / 0 - 20 °C
View Scheme
tert-butyl 4-(hydroxymethyl)piperidin-1-carboxylate
123855-51-6

tert-butyl 4-(hydroxymethyl)piperidin-1-carboxylate

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione / ethyl acetate / 4 h / Inert atmosphere; Reflux
2.1: tetrabutylammomium bromide; sodium hydroxide / dichloromethane; water / 0.5 h / 20 °C / Inert atmosphere
2.2: 5 h / 50 °C / Inert atmosphere
3.1: diphenylsilane; zinc(II) chloride; tetrakis(triphenylphosphine) palladium(0) / chloroform / 24 h / 20 °C
4.1: trifluoroacetic acid / dichloromethane / 4 h / 0 - 20 °C
View Scheme
Multi-step reaction with 3 steps
1.1: oxalyl dichloride; dimethyl sulfoxide; triethylamine / dichloromethane / 20 °C / Inert atmosphere
2.1: sodium hydride / tetrahydrofuran; mineral oil / 0.5 h
2.2: 2 h / 20 °C
3.1: palladium 10% on activated carbon; hydrogen / tetrahydrofuran / 0.33 h / 20 °C / 760.05 Torr
3.2: 3 h / 20 °C
View Scheme
tert-butyl 4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)piperidine-1-carboxylate
1020717-67-2

tert-butyl 4-((5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methyl)piperidine-1-carboxylate

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: diphenylsilane; zinc(II) chloride; tetrakis(triphenylphosphine) palladium(0) / chloroform / 24 h / 20 °C
2: trifluoroacetic acid / dichloromethane / 4 h / 0 - 20 °C
View Scheme
3,4-methoxycinnamic acid
2107-70-2

3,4-methoxycinnamic acid

debenzyldonepezil
120014-30-4

debenzyldonepezil

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: phosphorus pentoxide; toluene-4-sulfonic acid / 0.08 h / 120 °C
2.1: sodium hydride / tetrahydrofuran; mineral oil / 0.5 h
2.2: 2 h / 20 °C
3.1: palladium 10% on activated carbon; hydrogen / tetrahydrofuran / 0.33 h / 20 °C / 760.05 Torr
3.2: 3 h / 20 °C
View Scheme
3-Cyanobenzaldehyde
24964-64-5

3-Cyanobenzaldehyde

debenzyldonepezil
120014-30-4

debenzyldonepezil

1-(3-cyanobenzyl)-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine

1-(3-cyanobenzyl)-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine

Conditions
ConditionsYield
Stage #1: 3-Cyanobenzaldehyde; debenzyldonepezil In 1,2-dichloro-ethane
Stage #2: With sodium tris(acetoxy)borohydride; acetic acid In 1,2-dichloro-ethane at 20℃; for 3h;
100%
With sodium tris(acetoxy)borohydride; acetic acid In ethyl acetate; 1,2-dichloro-ethane
debenzyldonepezil
120014-30-4

debenzyldonepezil

5,6-dimethoxy-2-(piperidine-4-ylmethyl)-2,3-dihydro-1H-inden-1-one hydrochloride

5,6-dimethoxy-2-(piperidine-4-ylmethyl)-2,3-dihydro-1H-inden-1-one hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In water; toluene at 10℃; Temperature; Reflux;95.35%
2-chloro-N-(4-nitro-phenyl)-acetamide
17329-87-2

2-chloro-N-(4-nitro-phenyl)-acetamide

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(p-nitrophenyl)acetamide

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(p-nitrophenyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;93%
benzyl bromide
100-39-0

benzyl bromide

debenzyldonepezil
120014-30-4

debenzyldonepezil

donepezil
120014-06-4

donepezil

Conditions
ConditionsYield
With sodium carbonate In ethanol at 50 - 60℃; for 6h;92.3%
With triethylamine In dichloromethane for 4h; Heating / reflux;
Stage #1: benzyl bromide; debenzyldonepezil With tetrabutylammomium bromide; potassium carbonate In dichloromethane; water at 20℃;
Stage #2: With hydrogenchloride In methanol
2-nitrophenylmethyl bromide
3958-60-9

2-nitrophenylmethyl bromide

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-((1-(2-(2-nitrobenzyl))piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

2-((1-(2-(2-nitrobenzyl))piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 8h; Reflux;92%
1-bromomethyl-4-nitro-benzene
100-11-8

1-bromomethyl-4-nitro-benzene

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-((1-(2-(4-nitrobenzyl))piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

2-((1-(2-(4-nitrobenzyl))piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 8h; Reflux;92%
2-chloro-N-(6-methoxy-1,3-benzothiazol-2-yl)acetamide
3427-30-3

2-chloro-N-(6-methoxy-1,3-benzothiazol-2-yl)acetamide

debenzyldonepezil
120014-30-4

debenzyldonepezil

N-(6-methoxybenzo[d]thiazol-2-yl)-2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)acetamide

N-(6-methoxybenzo[d]thiazol-2-yl)-2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;92%
N-chloroacetyl-aniline
587-65-5

N-chloroacetyl-aniline

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-phenylacetamide

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-phenylacetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;92%
2-chloro-N-(4-fluorophenyl)acetamide
351-04-2

2-chloro-N-(4-fluorophenyl)acetamide

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(p-fluorophenyl)acetamide

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(p-fluorophenyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;91%
2-chloro-N-(4-chlorophenyl)acetamide
3289-75-6

2-chloro-N-(4-chlorophenyl)acetamide

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(p-chlorophenyl)acetamide

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(p-chlorophenyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;90%
debenzyldonepezil
120014-30-4

debenzyldonepezil

N-benzothiazol-2-yl-2-chloroacetamide
3028-02-2

N-benzothiazol-2-yl-2-chloroacetamide

N-(benzo[d]thiazol-2-yl)-2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)acetamide

N-(benzo[d]thiazol-2-yl)-2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;89%
debenzyldonepezil
120014-30-4

debenzyldonepezil

2-chloro-N-(6-nitro-1,3-benzothiazol-2-yl)acetamide

2-chloro-N-(6-nitro-1,3-benzothiazol-2-yl)acetamide

N-(6-nitrobenzo[d]thiazol-2-yl)-2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)acetamide

N-(6-nitrobenzo[d]thiazol-2-yl)-2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;89%
debenzyldonepezil
120014-30-4

debenzyldonepezil

N-(4-methoxyphenyl)-2-chloroacetamide
22303-36-2

N-(4-methoxyphenyl)-2-chloroacetamide

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(p-methoxyphenyl)acetamide

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(p-methoxyphenyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;89%
2-(bromomethyl)-6-fluoropyridine
100202-78-6

2-(bromomethyl)-6-fluoropyridine

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-((1-((6-fluoropyridin-2-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

2-((1-((6-fluoropyridin-2-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 8h; Reflux;88%
5-(chloromethyl)quinolin-8-ol
10136-57-9

5-(chloromethyl)quinolin-8-ol

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-((1-((8-hydroxyquinolin-5-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

2-((1-((8-hydroxyquinolin-5-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 8h; Reflux;88%
2-chloro-N-(6-fluorobenzo[d]thiazol-2-yl)acetamide
263239-23-2

2-chloro-N-(6-fluorobenzo[d]thiazol-2-yl)acetamide

debenzyldonepezil
120014-30-4

debenzyldonepezil

N-(6-fluorobenzo[d]thiazol-2-yl)-2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)acetamide

N-(6-fluorobenzo[d]thiazol-2-yl)-2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;88%
isopropyl formate
625-55-8

isopropyl formate

debenzyldonepezil
120014-30-4

debenzyldonepezil

4-(2,3-dihydro-5,6-dimethoxy-1-indanone-2-ylmethyl)piperidine-1-carbaldehyde

4-(2,3-dihydro-5,6-dimethoxy-1-indanone-2-ylmethyl)piperidine-1-carbaldehyde

Conditions
ConditionsYield
Stage #1: debenzyldonepezil With potassium carbonate In methanol; water at 20℃; for 2h;
Stage #2: isopropyl formate at 50℃; for 2h;
88%
debenzyldonepezil
120014-30-4

debenzyldonepezil

2-chloro-N-(6-methylbenzothiazol-2-yl)acetamide
3174-15-0

2-chloro-N-(6-methylbenzothiazol-2-yl)acetamide

N-(6-methylbenzo[d]thiazol-2-yl)-2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)acetamide

N-(6-methylbenzo[d]thiazol-2-yl)-2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;87%
2-chloro-N1-(3,4-dimethoxyphenyl)-acetamide
62593-78-6

2-chloro-N1-(3,4-dimethoxyphenyl)-acetamide

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(3,4-dimethoxyphenyl)acetamide

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(3,4-dimethoxyphenyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;87%
acrylonitrile
107-13-1

acrylonitrile

debenzyldonepezil
120014-30-4

debenzyldonepezil

3-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)propanenitrile

3-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)propanenitrile

Conditions
ConditionsYield
With sodium In methanol at 55℃; for 12h; Inert atmosphere;87%
4-Fluorobenzyl bromide
459-46-1

4-Fluorobenzyl bromide

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-((1-(4-fluorobenzyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one
351532-09-7

2-((1-(4-fluorobenzyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 8h; Reflux;86%
N-(p-tolyl)-2-chloroacetamide
16634-82-5

N-(p-tolyl)-2-chloroacetamide

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(p-tolyl)acetamide

2-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl)-N-(p-tolyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 40℃; for 12h;86%
(S)-2-[1-(tert-butoxycarbonylamino)-2-methylpropyl]thiazole-4-carboxylic acid
126300-99-0, 149356-90-1

(S)-2-[1-(tert-butoxycarbonylamino)-2-methylpropyl]thiazole-4-carboxylic acid

debenzyldonepezil
120014-30-4

debenzyldonepezil

C30H41N3O6S
1609138-31-9

C30H41N3O6S

Conditions
ConditionsYield
Stage #1: (S)-2-[1-(tert-butoxycarbonylamino)-2-methylpropyl]thiazole-4-carboxylic acid With 6-chloro-3-((dimethylamino)(dimethyliminio)methyl)-1H-benzo[d][1,2,3]triazol-3-ium-1-olatehexafluorophosphate(V); benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine In N,N-dimethyl acetamide at 0℃; for 0.166667h;
Stage #2: debenzyldonepezil In N,N-dimethyl acetamide at 20℃; for 18h;
85%
2-bromomethyl-3,5-dimethylpyridine
170289-36-8

2-bromomethyl-3,5-dimethylpyridine

debenzyldonepezil
120014-30-4

debenzyldonepezil

2-((1-((3,5-dimethylpyridin-2-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

2-((1-((3,5-dimethylpyridin-2-yl)methyl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 8h; Reflux;85%

120014-30-4Relevant articles and documents

Synthesis, molecular docking studies, and antimicrobial evaluation of new structurally diverse ureas

Patil, Mahadev,Poyil, Anurag Noonikara,Joshi, Shrinivas D.,Patil, Shivaputra A.,Patil, Siddappa A.,Bugarin, Alejandro

, p. 302 - 311 (2019)

A series of new urea derivatives (3a-p) have been synthesized from readily available isocyanates and amines in good to high yields. All synthesized compounds were fully characterized using 1H NMR, 13C NMR, IR, and mass spectrometry. Additionally, the structure of the compound (3n) was confirmed by single-crystal X-ray diffraction. Furthermore, all compounds were evaluated for antimicrobial activity against five bacteria and two fungi. Last but not the least, molecular docking studies with Candida albicans dihydropteroate synthetase were performed and the results are presented herein.

Two novel donepezil-lipoic acid hybrids: Synthesis, anticholinesterase and antioxidant activities and theoretical studies

Terra, Bruna S.,Da Silva, Pedro H. C.,Tramarin, Anna,Franco, Lucas L.,Da Cunha, Elaine F. F.,Macedo, Fernando,Ramalho, Teodorico C.,Bartolini, Manuela,Bolognesi, Maria L.,De Fátima, ?ngelo

, p. 738 - 747 (2018)

Alzheimer disease (AD) is a complex disease related to multiple pathogenic mechanisms. A strategy to develop effective drugs is based on the so-called multi-Target directed ligands (MTDL) by using hybrid compounds. So, in the present study, we have designed and synthesized two hybrids, containing the indanone-piperidine moiety of donepezil, a drug approved for the treatment of AD, and the lipoic acid scaffold, an antioxidant compound endowed with neuroprotective effects. One hybrid was synthesized in four steps with 42percent global yield, and the other hybrid in six steps with 19percent global yield. The latter hybrid displayed moderate inhibitory activity against human acetylcholinesterase (hAChE) and greater activity against human butyrylcholinesterases (hBuChE). The selectivity for hBuChE was further rationalized by theoretical study. Importantly, the second hybrid showed a good antioxidant activity, exhibiting better ability in scavenging 2,2-diphenyl- 1 picrylhydrazyl (DPPH) radicals than lipoic acid.

Chemoselective Alkylation of Aminoacetophenones with Alcohols by Using a Palladacycle-Phosphine Catalyst

Mamidala, Ramesh,Subramani, M. Siva,Samser, Shaikh,Biswal, Priyabrata,Venkatasubbaiah, Krishnan

, p. 6286 - 6296 (2018/11/23)

The development of efficient and environmentally benign palladacycle-phosphine catalyzed process to enable the formation of chemoselective C-alkylated or N-alkylated aminoacetophenones with alcohols is described. This methodology proved to be tunable by variation of the base and the temperature, which allows for the isolation of structurally diverse C-alkylated and N-alkylated aminoacetophenones. Moreover, this methodology has been applied to the synthesis of biologically and industrially important donepezil.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 120014-30-4